Work

Phase II study of bipolar androgen therapy combined with sipuleucel-T for patients with metastatic castration resistant prostate cancer (mCRPC).

Year: 2026

Type: conference-abstract

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e17081

Authors: Joseph W. Kim, Daniel P. Petrylak, Michael E. Hurwitz, William K. Oh, Curtis J. Perry, Samir Zaidi, Ping Mu, Isaac Kim, Jihoon Kang, Wei Cheng, David A. Braun, Isaac Yi Kim

Institutions: Yale Cancer Center, Yale University, Yale New Haven Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Dendreon Pharmaceuticals

OpenAlex ID: W7162679963

Cites:

Cited by:

Related to: